| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.3M | — | +14.9% |
| Cost of Revenue | $11.8M | — | +16.4% |
| Gross Profit | $1.5M | — | +5.0% |
| R&D Expense | $5.7M | — | -18.1% |
| SG&A Expense | $7.5M | — | -7.3% |
| Operating Income | -$13.9M | — | +11.4% |
| Net Income | -$12.7M | — | +66.2% |
| EPS (Basic) | -$0.53 | — | +87.7% |
| EPS (Diluted) | -$0.53 | — | +87.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $12.3M | +189.5% | -32.0% |
| Accounts Receivable | $2.9M | +30.0% | +10.6% |
| Inventory | $7.2M | -3.0% | +0.5% |
| Current Assets | $30.2M | +37.1% | -25.7% |
| Total Assets | $414.2M | +0.9% | -7.4% |
| Current Liabilities | $18.7M | +14.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.1M | — | +36.5% |
| Capital Expenditures | $1.1M | — | -77.7% |
| Investing Cash Flow | -$1.1M | — | +77.7% |
| Financing Cash Flow | $15.2M | — | -57.1% |
| Free Cash Flow | -$7.2M | — | +50.6% |
| -6.6% |
| Long-term Debt | $490.8M | +1.6% | +2.2% |
| Total Liabilities | $592.2M | +2.7% | +5.7% |
| Stockholders' Equity | -$178.0M | -7.1% | -32.4% |